Kansas City, Kan-   Richard Thomas, a heart failure patient, participated in a clinical trial for the ALT Flow II procedure at The University of Kansas Health System.

Diagnosed with heart failure rather than sarcoidosis, he underwent a procedure to place a shunt in his heart, improving his condition significantly.

Dr. Hirak Shah and Dr. Mark Wiley led the trial, which aims to decompress the heart and alleviate pressure on the lungs.  

Richard Thomas, patient

• Richard Thomas shares his experience of struggling with shortness of breath and being diagnosed with heart failure.
• Richard recounts his visit to the VA and the initial misdiagnosis of his condition as related to sarcoidosis.

Dr. Mark Wiley, Division Chief of Cardiovascular Medicine, The University of Kansas Health System

• Dr. Mark Wiley explains the unique aspects of the ALT Flow procedure, including the device's placement through the jugular vein.
• He describes the immediate pressure reduction experienced by Richard after the shunt was placed.

Dr. Hirak Shah, Transplantation Cardiologist, The University of Kansas Health System

• Dr. Hirak Shaw highlights the importance of decompressing the heart to alleviate pressure on the lungs.
• He discusses the rigorous screening process for the trial, including various tests and measurements.

Sophia Ruyle, Registered Nurse, The University of Kansas Health System

• Sophia Ruyle discusses the challenges of helping patients qualify for trials and the importance of staying optimistic.
• She shares her positive experience working with Richard and the importance of clinical trials.

On the next Morning Medical Update: A Life Saving Bone Marrow Transplant from Halfway Around the World: Hear from the German donor who stepped up to save the life of a stranger and how their new bond turned into a special friendship.